Navigation Links
Study highlights side effects felt by BRCA mutation carriers after cancer risk-reducing procedure
Date:5/30/2014

PHILADELPHIA The majority of women with cancer causing BRCA1 and BRCA2 mutations experience sexual dysfunction, menopausal symptoms, cognitive and stress issues, and poor sleep following prophylactic removal of their Fallopian tubes and ovaries - a procedure known as risk-reducing salpingo-oophorectomy (RRSO) - according to results of a new study from the Abramson Cancer Center and the Perelman School of Medicine at the University of Pennsylvania. The team's findings, which reaffirm the need for a better understanding of how to manage long-term effects of the risk-reducing procedure, will be presented during the annual meeting of the American Society of Clinical Oncology in Chicago's McCormick Place on Saturday, May 31, 2014 (abstract #1508).

"These results reinforce the need for care providers to better understand and communicate with patients about the possible long-term effects of bilateral RRSO," said lead author Susan Domchek, MD, director of Penn's Basser Research Center for BRCA. "Removal of the Fallopian tubes and ovaries is associated with a decreased risk of death from breast and ovarian cancer for BRCA carriers, and is one of the most important interventions we have at the current time. However, this procedure comes with a price, so it's extremely important that clinicians work with women to help alleviate symptoms."

The new study surveyed 637 women with BRCA1 or BRCA2 mutations who had undergone the risk-reducing surgical procedure to have both ovaries and Fallopian tubes removed. Domchek and colleagues assessed participant quality-of-life through a series of questionnaires. Results show that suboptimal scores were present in the majority of patients for the majority of measures. Specifically, 73 percent reported sexual dysfunction, such as the absence of satisfaction and presence of pain; 61 percent had problems sleeping; 57 percent had symptoms of menopause such as hot flashes and vaginal dryness; and 56 percent had elevated levels of stress. Hormone replacement therapy did help mitigate symptoms, particularly in women undergoing oophorectomy prior to age 50.

Currently, it is recommended that BRCA1/2 mutation carriers undergo oophorectomy between ages 35-40 given the substantial benefits in decreasing breast and ovarian cancer risk and improving overall survival. "Our work highlights the need for novel strategies to prevent breast and ovarian cancer. Despite the efficacy of oophorectomy, given the negative impact, we need to continue to strive towards other options for prevention".


'/>"/>

Contact: Katie Delach
katie.delach@uphs.upenn.edu
215-349-5964
University of Pennsylvania School of Medicine
Source:Eurekalert

Related medicine news :

1. Study Suggests Vaccine May Help Kids With Brain Cancer
2. Study reveals how cancer drug causes diabetic-like state
3. Coffee Drinking in Pregnancy Wont Lead to Sleepless Baby: Study
4. Lower GI problems plague many with rheumatoid arthritis, Mayo Clinic study finds
5. Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study
6. No Added Cancer Risk From Hip Replacement Materials: Study
7. Reported Decline in U.S. Pneumonia Deaths May Be False: Study
8. Early Study Finds Some Promise for Lung Cancer Vaccine
9. Narcissists Often Ace Job Interviews, Study Finds
10. Sexual objectification of female artists in music videos exists regardless of race, MU study finds
11. Soy may alleviate hot flashes in menopause, large-scale study finds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/8/2019)... ... October 08, 2019 , ... ... Ralphs, QFC and Fred Meyer, King Sooper, Fry’s, Roundy’s, Smiths and Dillons. , ... grain-free & gluten-free. , “Ingredient purity and fresh taste is paramount for ...
(Date:10/8/2019)... San Jose, CA (PRWEB) , ... October 08, 2019 , ... ... patients with gum disease in San Jose, CA experience relief from this common and ... as possible in order to save adults from living with uncomfortable symptoms, including tender ...
(Date:10/8/2019)... ... 2019 , ... PotentiaMetrics, an Austin, TX based healthcare data ... Officer. Dr. Henderson will be responsible for the development and management of the ... Chair of both the Informatics Governance and the Inpatient Clinical Informatics Committees at ...
(Date:10/8/2019)... ... October 08, 2019 , ... Smile Brands Inc. has been ... monitoring site, Comparably. Smile Brands, a leading dental support organization with nearly 440 affiliated ... to deliver Smiles for Everyone®. The Happiness Award is the latest in a ...
(Date:10/8/2019)... ... ... 2019, husband and wife dental team, Dr.’s Michael and Azita Mansouri, will open their Marietta ... year that Mansouri Family Dental Care & Associates has held the event to ... a great turnout, serving over 300 people in a single day in the past. Doors ...
Breaking Medicine News(10 mins):
(Date:10/8/2019)... ... October 08, 2019 , ... DuPont ... segment at the Healthcare Design Expo (HCD) from Nov. 3-5, 2019, in New ... for over 35 years. Since its installation in the early 1980s in the ...
(Date:10/8/2019)... ... 08, 2019 , ... Corteva Agriscience and MicroMGx today announced ... crop protection products. , Under the agreement, MicroMGx will apply its metabologenomics platform ... for the agriculture industry, Corteva will use those starting points to discover and ...
(Date:10/8/2019)... ... 08, 2019 , ... Liquid-filled capsules (LFC) are the primary ... capsules and liquid filled hard capsules. Liquid-in-bottle is another avenue for delivering lipid ... during early-phase development and commercial products. , In a live webinar ...
Breaking Medicine Technology: